Search Results

An Interview With Yann Gouëffic, MD, PhD

The vascular surgeon weighs in on the current reimbursement climate in France, concerns about radiation exposure, and what is needed most in future lower limb trials.

Global Perspectives on SFA Treatment: France

By Yann Gouë,ffic, MD, PhD

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

Perspectives: Does Care Drive Reimbursement or Vice Versa?

By Tony S. Das, MD, FACP, FACC; and Yann Gouëffic, MD, PhD

Panel Discussion: CFA Disease: Exploring Options in a Typically Surgical Indication

Moderator Peter A. Schneider, MD, asks Daniela Branzan, MD; Daniel Clair, MD; Tony Das, MD, FACC; and Yann Gouëffic, MD, PhD, about their approaches to CFA lesions, patient and clinical factors they consider, data that support an endovascular approach, preferred tools and rules of thumb, and how treatment of CFA disease looks in the future.

Must-Haves and Wishlists for BTK Devices

Experts weigh in on device limitations, imaging gaps, and the future of innovation in the below-the-knee space.

With Marianne Brodmann, MD; Yann Gouëffic, MD, PhD; and Michael C. Siah, MD

Image Fusion for Vascular Procedures

The impact and continuing development of image fusion for planning and guiding vascular repair.

By Stéphan Haulon, MD, PhD; Dominique Fabre, MD, PhD; Justine Mougin, MD; Philippe Charbonneau, MD; Antoine Girault, MD; Maxime Raux, MD; and Yann Gouëffic, MD, PhD

CLTI: Evidence, Tools, and Tactics

By Jos C. van den Berg, MD, PhD

The Latest in Complex EVAR

By Jason T. Lee, MD; and Stéphan Haulon, MD, PhD

Nine Months Later… An Interview With Konstantinos Katsanos, MD

Dr. Katsanos's thoughts regarding the vascular community's reaction to his group's meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.

With Konstantinos Katsanos, MSc, MD, PhD, EBIR